The Efficacy and Safety of CM082 Combined With Everolimus in Chinese Patients With Metastatic Renal Cell Carcinoma: a Randomized, Double-blind, Double Dummy, Multicenter Study
Phase of Trial: Phase II/III
Latest Information Update: 05 Jun 2018
At a glance
- Drugs Vorolanib (Primary) ; Everolimus
- Indications Renal cell carcinoma
- Focus Therapeutic Use
- Acronyms CONCEPT
- Sponsors AnewPharma
- 05 Jun 2018 According to the results presented at the 54th Annual Meeting of the American Society of Clinical Oncology, a total of 101 patients have been randomized currently.
- 05 Jun 2018 Trial design presented at the 54th Annual Meeting of the American Society of Clinical Oncology
- 09 Nov 2017 Status changed from not yet recruiting to recruiting.